Insufficient scRNA-seq data for expression of MAPK12 at single-cell level.
Insufficient scRNA-seq data for expression of MAPK12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1812.40 | 2615 / 2642 | 100% | 12.71 | 703 / 705 |
prostate | 100% | 1579.70 | 244 / 245 | 96% | 7.94 | 483 / 502 |
uterus | 100% | 2320.33 | 170 / 170 | 73% | 5.65 | 337 / 459 |
lung | 99% | 1252.27 | 573 / 578 | 73% | 5.82 | 848 / 1155 |
kidney | 99% | 1175.29 | 88 / 89 | 60% | 4.52 | 545 / 901 |
breast | 100% | 1144.16 | 457 / 459 | 50% | 2.41 | 560 / 1118 |
bladder | 100% | 949.62 | 21 / 21 | 44% | 2.70 | 223 / 504 |
skin | 66% | 708.43 | 1195 / 1809 | 78% | 7.17 | 367 / 472 |
esophagus | 88% | 798.21 | 1265 / 1445 | 55% | 3.59 | 101 / 183 |
adrenal gland | 66% | 318.12 | 171 / 258 | 72% | 5.06 | 166 / 230 |
thymus | 96% | 632.74 | 628 / 653 | 30% | 1.16 | 184 / 605 |
intestine | 95% | 684.92 | 918 / 966 | 31% | 1.72 | 165 / 527 |
ovary | 100% | 1747.67 | 180 / 180 | 21% | 0.80 | 89 / 430 |
stomach | 89% | 607.15 | 319 / 359 | 31% | 1.40 | 88 / 286 |
muscle | 100% | 14086.49 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 784.72 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1237.93 | 1199 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 916.12 | 853 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.53 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 84% | 8.10 | 67 / 80 |
pancreas | 17% | 67.66 | 55 / 328 | 64% | 3.44 | 114 / 178 |
tonsil | 0% | 0 | 0 / 0 | 69% | 3.85 | 31 / 45 |
blood vessel | 63% | 395.46 | 835 / 1335 | 0% | 0 | 0 / 0 |
liver | 12% | 52.26 | 26 / 226 | 46% | 3.38 | 188 / 406 |
peripheral blood | 22% | 397.49 | 202 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0000165 | Biological process | MAPK cascade |
GO_0007165 | Biological process | signal transduction |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0010952 | Biological process | positive regulation of peptidase activity |
GO_0045445 | Biological process | myoblast differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAPK12 |
Protein name | Mitogen-activated protein kinase 12 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) |
Synonyms | ERK6 SAPK3 hCG_2039437 |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK12 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases such as MAPKAPK2, which are activated through phosphorylation and further phosphorylate additional targets. Plays a role in myoblast differentiation and also in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells suggesting MAPK12 may inhibit cell proliferation while promoting differentiation. Phosphorylates DLG1. Following osmotic shock, MAPK12 in the cell nucleus increases its association with nuclear DLG1, thereby causing dissociation of DLG1-SFPQ complexes. This function is independent of its catalytic activity and could affect mRNA processing and/or gene transcription to aid cell adaptation to osmolarity changes in the environment. Regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage and G2 arrest after gamma-radiation exposure. MAPK12 is involved in the regulation of SLC2A1 expression and basal glucose uptake in L6 myotubes; and negatively regulates SLC2A4 expression and contraction-mediated glucose uptake in adult skeletal muscle. C-Jun (JUN) phosphorylation is stimulated by MAPK14 and inhibited by MAPK12, leading to a distinct AP-1 regulation. MAPK12 is required for the normal kinetochore localization of PLK1, prevents chromosomal instability and supports mitotic cell viability. MAPK12-signaling is also positively regulating the expansion of transient amplifying myogenic precursor cells during muscle growth and regeneration. . |
Accessions | B5MDL5 A8MY48 ENST00000395778.3 P53778 ENST00000215659.13 [P53778-1] ENST00000395780.5 ENST00000622558.4 [P53778-2] |